scholarly journals A Cost-of-Illness analysis of β-Thalassaemia major in children in Sri Lanka – Experience from a tertiary level teaching hospital 

2020 ◽  
Author(s):  
Hamish Reed-Embleton ◽  
Savinda Arambepola ◽  
Simon Dixon ◽  
Behrouz Nezafat Maldonado ◽  
Anuja Premawardhena ◽  
...  
Keyword(s):  
Sri Lanka ◽  
Teaching Hospital ◽  
Cost Of Illness ◽  
Economic Burden ◽  
Iron Chelation ◽  
Sri Lankan ◽  
Thalassaemia Major ◽  
Structured Interviews ◽  
Illness Study ◽  
Clinical Records

Abstract Background: Sri Lanka has a high prevalence of b-thalassaemia major. Clinical management is complex and long-term and includes regular blood transfusion and iron chelation therapy. The economic burden of β-thalassaemia for the Sri Lankan healthcare system and households is currently unknown.Methods: A prevalence-based, cost-of-illness study was conducted on the Thalassaemia Unit, Department of Paediatrics, Kandy Teaching Hospital, Sri Lanka. Data were collected from clinical records, consultations with the head of the blood bank and a consultant paediatrician directly involved with the care of patients, alongside structured interviews with families to gather data on the personal costs incurred such as those for travel. Results: Thirty-four children aged 2-17 years with transfusion dependent thalassaemia major and their parent/guardian were included in the study. The total average cost per patient year to the hospital was $US 2601 of which $US 2092 were direct costs and $US 509 were overhead costs. Mean household expenditure was $US 206 per year with food and transport per transfusion ($US 7.57 and $US 4.26 respectively) being the highest cost items. Nine (26.5%) families experienced catastrophic levels of healthcare expenditure (>10% of income) in the care of their affected child. The poorest households were the most likely to experience such levels of expenditure. Conclusions: β-thalassaemia major poses a significant economic burden on health services and the families of affected children in Sri Lanka. Greater support is needed for the high proportion of families that suffer catastrophic out-of-pocket costs.

scholarly journals A Cost-of-Illness analysis of β-Thalassaemia major in children in Sri Lanka

2020 ◽  
Author(s):  
Hamish Reed-Embleton ◽  
Savinda Arambepola ◽  
Simon Dixon ◽  
Behrouz Nezafat Maldonado ◽  
Anuja Premawardhena ◽  
...  
Keyword(s):  
Sri Lanka ◽  
Cost Of Illness ◽  
Iron Chelation ◽  
Sri Lankan ◽  
Thalassaemia Major ◽  
Structured Interviews ◽  
High Prevalence ◽  
Illness Study ◽  
Clinical Records

Abstract Background Sri Lanka has a high prevalence of β-thalassaemia major. Clinical management is complex and long-term and includes regular blood transfusion and iron chelation therapy. The economic burden of β-thalassaemia for the Sri Lankan healthcare system and households is currently unknown. Methods A prevalence-based, cost-of-illness study was conducted on the Thalassaemia Unit, Department of Paediatrics, Kandy Teaching Hospital, Sri Lanka. Data were collected from clinical records, consultations with the head of the blood bank and a consultant paediatrician directly involved with the care of patients, alongside structured interviews with families to gather data on the personal costs incurred such as those for travel. Results Thirty-four children aged 2-17 years with transfusion dependent thalassaemia major and their parent/guardian were included in the study. The total average cost per patient year to the hospital was $US 2601 of which $US 2092 were direct costs and $US 509 were overhead costs. Mean household expenditure was $US 206 per year with food and transport per transfusion ($US 7.57 and $US 4.26 respectively) being the highest cost items. Nine (26.5%) families experienced catastrophic levels of healthcare expenditure (>10% of income) in the care of their affected child. The poorest households were the most likely to experience such levels of expenditure.

scholarly journals A cost-of-illness analysis of β-Thalassaemia major in children in Sri Lanka – experience from a tertiary level teaching hospital

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Hamish Reed-Embleton ◽  
Savinda Arambepola ◽  
Simon Dixon ◽  
Behrouz Nezafat Maldonado ◽  
Anuja Premawardhena ◽  
...  
Keyword(s):  
Sri Lanka ◽  
Teaching Hospital ◽  
Cost Of Illness ◽  
Tertiary Level ◽  
Thalassaemia Major

scholarly journals PCV40 Economic Burden of Heart Failure in Saudi Arabia: A Cost of Illness Study

2020 ◽  
Vol 23 ◽  
pp. S494
Author(s):  
A. Alghamdi ◽  
E. Alqarni ◽  
A. Altowaijri
Keyword(s):  
Heart Failure ◽  
Saudi Arabia ◽  
Cost Of Illness ◽  
Economic Burden ◽  
Illness Study ◽  
Cost Of Illness Study

scholarly journals Healthcare Expenditures Associated with Heart Failure in Saudi Arabia: A Cost of Illness Study

Healthcare ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 988
Author(s):  
Ahmed Alghamdi ◽  
Eman Algarni ◽  
Bander Balkhi ◽  
Abdulaziz Altowaijri ◽  
Abdulaziz Alhossan
Keyword(s):  
Heart Failure ◽  
Saudi Arabia ◽  
Cost Of Illness ◽  
Economic Burden ◽  
Indirect Costs ◽  
Health Care Expenditures ◽  
Decision Makers ◽  
Hospitalization Costs ◽  
Illness Study ◽  
The Cost

Heart failure (HF) is considered to be a global health problem that generates a significant economic burden. Despite the growing prevalence in Saudi Arabia, the economic burden of HF is not well studied. The aim of this study was to estimate the health care expenditures associated with HF in Saudi Arabia from a social perspective. We conducted a multicenter cost of illness (COI) study in two large governmental centers in Riyadh, Saudi Arabia using 369 HF patients. A COI model was developed in order to estimate the direct medical costs associated with HF. The indirect costs of HF were estimated based on a human capital approach. Descriptive and inferential statistics were analyzed. The direct medical cost per HF patient was $9563. Hospitalization costs were the major driver in total spending, followed by medication and diagnostics costs. The cost significantly increased in line with the disease progression, ranging from $3671 in class I to $16,447 in class IV. The indirect costs per working HF patient were $4628 due to absenteeism, and $6388 due to presenteeism. The economic burden of HF is significantly high in Saudi Arabia. Decision makers need to focus on allocating resources towards strategies that prevent frequent hospitalizations and improve HF management and patient outcomes in order to lower the growing economic burden.

Significance of operational capabilities of suppliers on the front-end decision making in apparel product innovation in Sri Lanka

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Niromi Seram ◽  
Julian Nanayakkara ◽  
Gamini Lanarolle
Keyword(s):  
Decision Making ◽  
Sri Lanka ◽  
Product Innovation ◽  
Sri Lankan ◽  
Structured Interviews ◽  
Apparel Manufacturing ◽  
Content Type ◽  
Front End ◽  
Operational Capabilities ◽  
Apparel Product

Purpose The suppliers are recognized as important external sources who can significantly contribute by working together with the buyer during the innovation process. Operational capabilities of suppliers can be one of the considerable factors when selecting them to participate in the activities at the front-end of innovation. However, proper understanding of the influence of operational capabilities of suppliers on front-end decision-making in apparel product innovation is still very limited particularly in the context of the Sri Lankan apparel industry. Therefore, this study aims to explore the influence of operational capabilities of suppliers on the front-end decision making in apparel product innovation in Sri Lanka. Design/methodology/approach Both semi-structured interviews and a questionnaire survey were used as data collection techniques. Six senior managers for the interviews and 60 participants for the questionnaire were randomly selected. All those who participated in interviews and the questionnaire respondents have been involved in the front-end of innovation in different apparel manufacturing organizations in Sri Lanka. Findings The results indicated that the operational capabilities of suppliers had a direct positive influence on front-end decision-making, and the suppliers’ production flexibility was found to be the most influential. Further, the results highlighted that 27.3% of the front-end decisions associated with apparel product innovation in Sri Lanka were influenced by the factors governing operational capabilities of suppliers. Originality/value The findings of the research will be beneficial for both academia and industry. The findings will be useful to extend the current understanding and make a noteworthy contribution to this topic and to provide useful and practical guidance to material suppliers and supporting industries who work with Sri Lankan apparel manufacturing.

scholarly journals Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]

2018 ◽  
Vol Volume 10 ◽  
pp. 613-614
Author(s):  
Umberto Restelli ◽  
Giovanni Luca Ceresoli ◽  
Davide Croce ◽  
Laura Evangelista ◽  
Lorenzo Maffioli ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cost Of Illness ◽  
Economic Burden ◽  
Illness Study ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant ◽  
Cost Of Illness Study

scholarly journals APPLICABILITY OF POLYMER BUILDING MATERIALS FOR PRODUCTIVITY ENHANCEMENT AND COST REDUCTION IN SRI LANKAN BUILDING INDUSTRY

2021 ◽  
Author(s):  
S.D. Wijeratne ◽  
◽  
K.A.K. Devapriya ◽  
S.D. Gallage ◽  
◽  
...  
Keyword(s):  
Sri Lanka ◽  
Questionnaire Survey ◽  
Cost Reduction ◽  
Building Materials ◽  
Raw Materials ◽  
Quantitative Model ◽  
Building Construction ◽  
Polymer Materials ◽  
Sri Lankan ◽  
Structured Interviews

Building construction contributes to a substantial consumption of raw materials compared to other sectors in Sri Lanka. Despite the excessive consumption of raw materials, industry is suffering due to low productivity and economic inefficiency. Thus, the circumstance has led to employ alternative building materials to overcome productivity and cost inefficiency with favourable impacts on sustainability. Polymer has become a global phenomenon with increasing demand as sustainable alternative. Polymer facilitates multiple applications in building construction due to its supreme properties and characteristics. Thus, this research focused develop a quantitative model based on factors related to productivity enhancement and cost reduction to measure the applicability of polymer materials in Sri Lankan building construction. A mixed approach consisting of semi structured interviews followed by a questionnaire survey was adapted for conduct this study. 12 experts were selected for the semi structured interviews and 34 respondents participated for the questionnaire survey. The significance of favourable impact to the productivity and cost efficiency of using polymer materials have been identified in the study. The study discussed the applicability of polymer types in building sector in Sri Lanka and derived resulted in a quantitative model to measure applicability of polymer adoption in the terms of productivity and cost related factors. Study concluded that inherent properties of polymers, buildability, ability to prefabricate, life cycle cost, handling would improve the applicability to local context. Further, relationship identified through the regression model would assist practitioners to select polymer materials while enabling researchers to improve the quality of the products.

scholarly journals ECONOMIC BURDEN OF DIABETES IN TELANGANA: A COST OF ILLNESS STUDY

2020 ◽  
Vol 02 (02) ◽  
pp. 148-151
Author(s):  
HEMANTH KUMAR ANNAM ◽  
PRIYANKA NOMULA ◽  
HARIKA GORLA
Keyword(s):  
Cost Of Illness ◽  
Economic Burden ◽  
Illness Study ◽  
Cost Of Illness Study

scholarly journals The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation

2018 ◽  
Vol 90 (9) ◽  
pp. 101-109 ◽  
Author(s):  
I E Chazova ◽  
T V Martynyuk ◽  
Z S Valieva ◽  
S N Nakonechnikov ◽  
S V Nedogoda ◽  
...  
Keyword(s):  
Pulmonary Hypertension ◽  
Cost Of Illness ◽  
Economic Burden ◽  
Chronic Thromboembolic Pulmonary Hypertension ◽  
Medical Costs ◽  
Patient Registry ◽  
Specific Therapy ◽  
Illness Study ◽  
Thromboembolic Pulmonary Hypertension ◽  
Cost Of Illness Study

Aim. The aim of current study was to estimate the economic burden of the chronic thromboembolic pulmonary hypertension (CTEPH) in Russia based on patient registry. Materials and methods. Cost of illness study was based on data derived from CTEPH patient registry that was developed at the Division of hypertension of FSBI “National Medical Research Center of Cardiology”. Demographic and clinical patient characteristics were analyzed with descriptive statistic methods. Cost of illness study was performed from the state perspective and with bottom-up approach. Bootstrapping was used for calculation of average costs per patient/year. Within the study direct costs (medical costs: outpatient, inpatient, emergency, PAH-specific therapy, concomitant therapy; non-medical costs: pension due to disability status, payments for patients on sick-leave) and indirect costs (loss in GDP) were estimated. Results. Overall, 113 CTEPH patients (67 women and 46 men) from 33 Russian regions were included, mean age of patients with CTEPH was 54.6±13.95 years. Most of the patients (55%) were in able-bodied age. It was found that about half of patients with diagnosed CTEPH had a disability. Average duration of disease at the time of analysis was 6.88±11.41 years. Period from the first occurrence of symptoms to the confirmation of diagnosis of CTEPH was 2.58±5.21 years on average. More than 70% of patients had III and IV FC (WHO) at the time of diagnosis. Mean number of outpatient visits was 1.97±1.65 per patient/year, and inpatient visits were reported for 59% of patients. About 54% of patients used PAH-specific therapy, moreover 46% patients had interruptions of PAH-specific therapy (58.4±66.3 days). The total costs of CTEPH per patient/year were calculated as 805,901 RUB. The overall burden of CTEPH in Russia for total CTEPH population (470 patients) was 379 million RUB per year. Conclusions. CTEPH is the rare disease that is characterized with later diagnosis due to absence of disease-specific symptoms. Therefore economic burden of the CTEPH is significantly low in comparison to widespread cardiovascular diseases. Development of network of expert PH-centers and increase of the access for PAH-specific therapy will help to increase the quality of health care for patients with CTEPH.

Sign in / Sign up

Export Citation Format

Share Document